Cargando…
Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure
Auto-antibodies (Abs) to type I interferons (IFNs) are found in up to 25% of patients with severe COVID-19, and are implicated in disease pathogenesis. It has remained unknown, however, whether type I IFN auto-Abs are unique to COVID-19, or are also found in other types of severe respiratory illness...
Autores principales: | Ghale, Rajani, Spottiswoode, Natasha, Anderson, Mark S., Mitchell, Anthea, Wang, Grace, Calfee, Carolyn S., DeRisi, Joseph L., Langelier, Charles R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756918/ https://www.ncbi.nlm.nih.gov/pubmed/36527083 http://dx.doi.org/10.1186/s12931-022-02283-4 |
Ejemplares similares
-
Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections
por: Serpa, Paula Hayakawa, et al.
Publicado: (2022) -
Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021) -
Subphenotypes Assigned to Pediatric Acute Respiratory Failure Patients Show Differing Outcomes
por: Flori, Heidi R., et al.
Publicado: (2023) -
The attributable mortality of acute respiratory distress syndrome
por: Auriemma, Catherine L., et al.
Publicado: (2020) -
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis
por: Lemarquis, Andri, et al.
Publicado: (2021)